Saturday, January 14, 2017 1:40:59 PM
https://clinicaltrials.gov/ct2/show/study/NCT02981550?view=results
investors slowly seem to realize that BTHCF is highly undervalued.
BTHCF Market Value $8.860.000
BLOZF Market Value $ 51.370.000
yet BTHCF has already started a trial with an advanced stage technology (NA-NOSE). BLOZF hasnt started a trial yet. furthermore FAIMS from yost is not an advanced stage technology. NA-NOSE has gone through trials in 22 different countries with thousands of patients in the past. furthermore the medical market BTHCF is aiming for is WAY larger than the market BLOZF is going for. furthermore we just got the cures act signed (see sticky). BTHCF should be valued higher or at least equal to BLOZF. BTHCF has been valued higher in the past and it will climb back up there imo.
dont get me wrong though... BLOZF will bring huge profits in the end also!
i see BTHCF getting into the $1 usd range.
thats the inventor of NA-NOSE dr. haick with bill gates. that kind of shows what kind of tech this is and what kind of ppl are interested in it... this tech will change the world imo.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM